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We examined the prognostic value of stress echocardiography appropriateness criteria for evaluation of
valvular heart disease in 100 consecutive patients. Of the studies, 49%, 36%, and 15% were classiﬁed as
appropriate, uncertain, and inappropriate, respectively. Over a median of 12.6 months, 24 events (12
deaths and 12 heart failure admissions) occurred. The 12-month event-free survival was signiﬁcantly
reduced in patients with appropriate or uncertain studies compared with patients with inappropriate
studies (p ¼ 0.04 and p ¼ 0.005, respectively). There was no survival difference between patients with
an appropriate or uncertain indication (p ¼ 0.1). The only independent predictors of events were a
positive stress echocardiogram (hazard ratio: 15.5, p < 0.0001) and left ventricular ejection fraction
(hazard ratio: 0.95, p ¼ 0.02). The appropriateness criteria for evaluation of valvular heart disease
provide the ability to differentiate between patients at high- (appropriate group) and low-
(inappropriate group) risk of cardiac events. Reclassiﬁcation of the uncertain group may improve the
differential value of these criteria.he growth of cardiovascular imaging over
the past 2 decades (1), coupled with
increasing associated economic costs, led
the American College of Cardiology
Foundation to publish appropriateness criteria
(2). The purpose was to promote efﬁcient and
effective use of cardiovascular imaging. Seve-
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patients with coronary artery disease (3–5) as a
tool to distinguish between patients at high
probability of a positive result and an adverse
prognosis and those patients with a low prob-
ability of a positive result and an excellent
prognosis. The application of these criteria in
clinical practice may limit the number of
unnecessary investigations performed.
Population studies have shown that the
prevalence of valvular heart disease increases
with age and is associated with excess cardiac
mortality (6). The burden of valve disease in the
population is likely to increase as the population
ages. The physiological effect of valvular heart
disease is a dynamic process. Alterations in
loading conditions, valve compliance, and ven-
tricular performance that occur on exercise/
Table 1. Criteria for a Positive Stress Echocardiogram
Valve Assessment Criteria for Positive Test Results
Assessment of mitral regurgitation in patients
with symptoms but mild or moderate mitral
regurgitation at rest
Increase in severity of mild or moderate mitral
regurgitation to severe. Effective oriﬁce area
$0.4 cm2 (organic) or $0.2 cm2 (functional)
Assessment of asymptomatic severe mitral
regurgitation
Increase in pulmonary artery systolic pressure
>60 mm Hg
Assessment of mitral stenosis in patients with
symptoms but mild or moderate mitral
stenosis at rest
Increase in the mean transmitral gradient
$15 mm Hg or estimated pulmonary artery
systolic pressure $60 mm Hg
Assessment of asymptomatic severe mitral
stenosis
As above and symptoms
Assessment of asymptomatic severe aortic
stenosis (AVA <1 cm2)
Increase in mean transaortic gradient
$20 mm Hg
Assessment of asymptomatic severe aortic
regurgitation
Lack of increase in LVEF $5% or exercise-
induced reduction in LVEF
AVA ¼ aortic valve area; LVEF ¼ left ventricular ejection fraction.
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988altered ﬂow states can uncover the
severity of valve dysfunction and thereby
a patient’s symptoms status (7). Over the
past decade, several investigators have
identiﬁed the value of stress echo-
cardiography to correlate exercise-
induced symptoms with changes in
hemodynamics in mitral valve disease in
patients with only mild or moderate
resting valve disease (8–12) and the
prognostic value in asymptomatic
patients with severe aortic stenosis
(13,14). Furthermore, the use of
dobutamine stress echocardiography is
useful to identify truly severe aortic
stenosis in low-ﬂow, low-gradient aortic
stenosis (15,16). Recent guidelines
advocate the use stress echocardiography
to help risk-stratify patients to aid the
diagnosis and, in selected cases, guide
decisions for valve intervention (17). No
data exist with regard to the value of
stress echocardiography appropriateness
criteria in these groups.
We therefore sought to investigate
the prognostic value of stress echo-
cardiography and the clinical utility of
appropriateness criteria in patients
referred for stress echocardiography to
investigate valvular heart disease.
Methods
One hundred consecutive patients who
underwent stress echocardiography in
the echocardiography laboratory at our
institution between October 2010 and
May 2012 were evaluated. The study
was approved by the institutional review
board.
Valve protocols. For assessment of the
severity of exercise-induced mitral
regurgitation, mitral stenosis, and
asymptomatic severe aortic stenosis and
regurgitation, a symptom-limited bicy-
cle test was performed with patients in a
semisupine position on a tilting exercise
bicycle. Baseline images were acquired.
Exercise was performed starting at a
workload of 25 W. Every 2 min, the
workload increased by 25 W. Two-
dimensional and Doppler echocardiog-
raphy measurements were made at rest
and at peak exercise. The test wasstopped if limiting symptoms including
chest pain and dyspnea occurred or
signiﬁcant adverse hemodynamic
changes occurred.
For all tests, both at rest and peak
stress, left ventricular systolic and dia-
stolic volumes and left ventricular ejec-
tion fraction were calculated using
Simpson biplane method, and estimated
pulmonary artery systolic pressure was
calculated from the transtricuspid
pressure gradient using the modiﬁed
Bernoulli equation, taking inferior vena
cava size and respiratory variation into
account. The severity of mitral regur-
gitation at rest and stress was measured
using the proximal isovelocity method.
A sample of 10 patients was reread to
calculate interobserver variability. In rare
cases in which this parameter could not
be obtained, the vena contracta was
measured. The severity of mitral stenosis
was assessed by measuring the mean
transmitral gradient at rest and at peak
stress. For asymptomatic severe aortic
stenosis, the change in mean transaortic
pressure gradient between rest and
stress was measured. For patients with
asymptomatic severe aortic regur-
gitation, left ventricular ejection fraction
and left ventricular volumes were
assessed at rest and at stress. The criteria
used for a positive test are summarized
in Table 1.Low-dose dobutamine protocol for low-
gradient, low-ﬂow, and low–ejection
fraction severe aortic stenosis. The
deﬁnition of low-ﬂow, low-gradient,
low–ejection fraction severe aortic ste-
nosis was aortic valve area#1 cm2, mean
gradient <40 mm Hg, and ejection
fraction #40%. After comprehensive
echocardiography, a dobutamine infu-
sion of 5 mg/kg/min was started. This
was increased in 5 mg/kg/min in-
crements every 5 min to a maximum of
20 mg/kg/min. At each stage, the left
ventricular outﬂow tract Doppler (pulse
wave), transaortic Doppler (continuous
wave) and biplane left ventricular vol-
umes were measured. The transaortic
gradient was calculated from the sim-
pliﬁed Bernoulli equation. The left
ventricular outﬂow tract diameter was
measured at rest and assumed to be
constant throughout the test. The aortic
valve area was calculated using the con-
tinuity equation. The presence of con-
tractile reserve was deﬁned as an increase
in stroke volume by$20%. Severe aortic
stenosis was identiﬁed when contractile
reserve was present, there was an increase
in mean transaortic gradient, and the
aortic valve area remained <1 cm2.
Moderate aortic stenosis was identiﬁed
when contractile reserve was present and
there was an increase in aortic valve area
>1 cm2. When contractile reserve was
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989not present, it was not possible to deter-
mine the exact severity of aortic stenosis.
Pre-test and outcome data. Demo-
graphic factors, risk factors, medical
history, medication, and stress echocar-
diography test indications and results
were prospectively collected at the time
stress echocardiography was performed.
Follow-up and outcome data were
derived from the hospital electronic
patient record data, which include out-
patient and inpatient encounters.
Follow-up time was calculated from the
initial test date to either the date of a
cardiac event or the date of the last con-
tact with the patient. Indications for
stress echocardiography were classiﬁed as
appropriate, inappropriate, or uncertain
according to guidelines (2). Worsening
heart failure was deﬁned as worsening
New York Heart Association functional
class or signs of ﬂuid retention.Table 2. Baseline Demographic Factors
Appropriat
(n [ 49)
Age, yrs 65.3  17.5
Female 26 (53.0)
Median follow-up, months 12.2 (7.3–15
Smoker 5 (10.2)
Hypertension 18 (36.7)
Diabetes 5 (10.2)
Hyperlipidemia 10 (20.4)
Previous CABG 5 (10.2)
Previous PCI 7 (14.3)
LVEF, % 50.8  14.5
LVEDD, cm 5.4  0.7
Interventricular septum thickness, cm 1.0  0.2
Left atrial diameter, cm 4.4  0.8
Mitral stenosis 3 (6.1)
Mitral regurgitation
Functional 10 (20.4)
Degenerative 7 (14.3)
Aortic stenosis
Low gradient, low ﬂow 26 (53.1)
Severe, asymptomatic 0 (0.0)
Aortic regurgitation 3 (6.1)
Values are mean  SD, n (%), or n (interquartile range).
CABG ¼ coronary artery bypass graft; LV ¼ left ventricular; L
ventricular ejection fraction; PCI ¼ percutaneous coronary interEach patient was categorized by 2
independent reviewers of the data. In
cases in which the classiﬁcation was not
consistent between the 2 reviewers, the
patient data was jointly reviewed and a
consensus opinion was reached between
the 2 reviewers.
Statistics. Data are expressed as median
and interquartile range or number and
percentage. The chi-square test was used
to compare categorical variables. When
the number of categorical variables was
<5, the Fisher exact test was used. The
endpoint was a composite of admission
for worsening heart failure or death
(whichever occurred ﬁrst). Logistic
regressionwas used to identify predictors
of a positive stress echocardiogram. The
Kaplan-Meier method was used for
event-free survival analysis. The log-
rank test was used to compare differ-
ences between survival curves. Coxe Uncertain
(n [ 36)
Inappropriate
(n [ 15) p Value
71.9  11.5 62.5  19 0.17
20 (55.6) 8 (53.3) 0.97
.6) 13.0 (8.4–23) 13.0 (12–14.5) 0.19
3 (8.3) 2 (13.3) 0.86
16 (44.4) 6 (40.0) 0.78
5 (13.9) 3 (20.0) 0.61
12 (33.3) 5 (33.3) 0.22
4 (11.1) 2 (13.3) 0.94
5 (13.9) 2 (13.3) 0.99
58.9  10.4 57.5  14.4 0.08
5.3  0.5 5.1  0.8 0.44
1.1  0.2 1.0  0.1 0.21
4.5  0.9 4.0  0.5 0.22
2 (5.6) 3 (20.0) 0.18
14 (38.9) 6 (40.0) 0.12
10 (27.8) 5 (33.3) 0.17
0 (0.0) 0 (0.0) <0.0001
8 (22.2) 0 (0.0) 0.001
2 (5.5) 1 (6.6) 0.98
VEDD ¼ left ventricular end-diastolic diameter; LVEF ¼ left
vention.regression analysis was used to identify
predictors of survival. For quantiﬁcation
of mitral regurgitation, interobserver
concordance was expressed as exact
agreement. All tests of signiﬁcance were
2 sided. A p value<0.05 was considered
statistically signiﬁcant. Statistical analy-
sis was performed using StatsDirect
Version 2.5.7 (StatsDirect, Altrincham,
United Kingdom).
Results
Between October 2010 and May 2012,
100 consecutive patients who under-
went stress echocardiography were
identiﬁed. Baseline demographic fac-
tors are documented in Table 2.
Of the 100 patients who were
assessed with stress echocardiography
for the evaluation of valvular heart dis-
ease, 34 (34%), 52 (52%), 8 (8%), and
6 (6%) studies were for assessment of
aortic stenosis, mitral regurgitation,
mitral stenosis, and aortic regurgitation,
respectively. Of the 100 patients, 49
(49%), 36 (36%), and 15 (15%) were
classiﬁed as appropriate, uncertain, and
inappropriate, respectively.
A positive test result was identiﬁed in
32 patients (32%). A positive test result
occurred in 19 patients (38.8%) with an
appropriate indication, in 13 patients
(36.1%) with an uncertain indication,
and in no patients with an inappropriate
indication (p < 0.0001). Exact agree-
ment between graders was obtained in
92 (92%) patients. In 8 patients, a con-
sensus opinion was reached. Mitral
regurgitation quantiﬁcation by the
proximal isovelocity method was ach-
ieved in 46 (88.5%) of the 52 patients
undergoing mitral regurgitation assess-
ment. Interobserver differences ranged
from 0% to 5% (mean, 1.7%). Exact
agreement between graders was reached
in 70% of patients. The remaining 6
patients were graded using a combina-
tion of vena contracta and jet area.
During a median follow-up of 12.6
months (interquartile range, 8.8 to 17.5
months), a total of 24 events (12 heart
failure admissions and 12 deaths)
occurred. Of the 32 patients with
Figure 1. Kaplan-Meier Survival Curves Stratiﬁed by a Positive or Negative Stress Echocardiogram
Signiﬁcantly reduced event-free survival in patients with a positive stress echocardiogram compared with
patients with a negative stress echocardiogram.
Table 3. Clinical and Demographics Predictors of a Positive Stress Echocardiogram
Odds Ratio (95% CI) p Value
Age, yrs 1.01 (0.98–1.05) 0.51
Female 0.67 (0.68–5.61) 0.21
Smoker 0.99 (0.12–8.12) 0.99
Hypertension 1.91 (0.64–5.66) 0.99
Diabetes 0.29 (0.04–1.95) 0.20
Hyperlipidemia 0.55 (0.16–1.92) 0.35
LVEF, % 0.99 (0.96–1.04) 0.95
LVEDD, cm 0.77 (0.32–1.84) 0.55
Interventricular septum thickness, cm 0.37 (0.02–6.72) 0.50
Left atrial diameter, cm 0.75 (0.33–1.73) 0.06
Appropriate indication 6.2 (0.61–7.22) 0.98
Inappropriate indication 2.48 (0.22–3.56) 0.98
Uncertain indication 4.1 ( 0.42–5.1) 0.99
CI ¼ conﬁdence interval; other abbreviations as in Table 2.
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990positive test results, events occurred in
18 (56.3%) patients compared with
only 6 (8.8%) events in the 68 patients
with a negative stress echocardiogram
(p < 0.001). Figure 1 shows the
Kaplan-Meier survival curves of the
patients with positive and negative
stress echocardiograms. Logistic reg-
ression showed no baseline demo-
graphic or clinical features were
independent predictors of a positive
valve stress echocardiogram (Table 3).
Events occurred in 11 patients
(22.4%) with an appropriate indication,
in 13 patients (36.1%) with an uncertain
indication, and in no patients with an
inappropriate indication. Kaplan-Meier
curves (Fig. 2) showed that event-free
survival was signiﬁcantly reduced in
patients with an appropriate indication
compared with those with an inappro-
priate indication (p ¼ 0.04) and in
patients with an uncertain indication
compared with those with an inappro-
priate indication (p ¼ 0.005). There
was no signiﬁcant survival difference
between patients with an appropriate or
uncertain indication (p ¼ 0.1). Cox
regression analysis showed that a pos-
itive stress echocardiogram (hazard ratio:
15.5; interquartile range, 4.2 to 57.4;
p < 0.0001) and left ventricular ejection
fraction (hazard ratio: 0.95, interquartile
range, 0.91 to 0.98; p ¼ 0.02) were the
only independent predictors of events
among prognostically important clini-
cal and echocardiographic variables
(Table 4). Although there was a higher
mortality rate in the appropriate group
(8 deaths [16.3%]) and uncertain group
(4 deaths [11.1%]) compared with the
inappropriate group (no deaths), this
was not statistically signiﬁcant.
Of the 32 patients with a positive test
result, 25 (78.1%) underwent a valve
intervention, of whom 12 patients had an
event before intervention. Seven patients
(21.9%) with a positive test result were
medically managed, 6 of whom had an
event. The 25 valve interventions were 6
surgical aortic valve replacements, 8
mitral valve replacements, 7 transcatheter
aortic valve implantation, and 4 percuta-
neousmitral valve repair. No patient witha negative test result underwent valve
intervention. Valve intervention was
performed in 12 patients (24.5%) with an
appropriate indication, in 13 patients
(36%) with an uncertain indication, and
in no patients with an inappropriate
indication (p < 0.0001). The 30-day
periprocedure mortality rate was 8%
(2 patients). At 6 months, no further
patients had died.
Discussion
This study identiﬁes the clinical value
of performing stress echocardiography
in patients with valvular heart disease.
Second, it demonstrates the beneﬁts ofapplying appropriateness criteria to this
patient group. Third, it also demon-
strates that appropriateness criteria in
valvular heart disease need to be further
reﬁned.
Fifty-six percent of patients with a
positive stress echocardiography test
result had an event within 12 months,
whereas only 9% of those with a negative
test result had an event. Indeed, a pos-
itive stress echocardiogram and reduced
left ventricular ejection fraction were the
only independent predictors of events
among all prognostically important
clinical and resting echocardiographic
parameters. This illustrates the prog-
nostic value of stress echocardiography
Figure 2. Kaplan-Meier Survival Curves Stratiﬁed by Stress Echocardiography Appropriateness
Criteria: Appropriate, Uncertain, and Inappropriate
Signiﬁcantly reduced event-free survival in patients classiﬁed as appropriate and uncertain compared with
patients classiﬁed as inappropriate.
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991in the assessment of patients with valv-
ular heart disease. Previous studies
examined the diagnostic utility and
prognostic role of stress echocardiog-
raphy in speciﬁc patient groups (e.g.,
severe asymptomatic aortic stenosis,
severe asymptomatic mitral regur-
gitation, mild mitral stenosis in research
protocols within specialist echocardiog-
raphy laboratories with research interests
in valvular heart disease) (8–16). This
study demonstrates the feasibility and
prognostic value of stress echocardiog-
raphy when incorporated into a clinical
service where procedures are performedTable 4. Baseline Clinical and Echocardiographic Pr
Age, yrs
Female
Smoker
Hypertension
Diabetes
Hyperlipidemia
LVEF, %
LVEDD, cm
Interventricular septum thickness, cm
Left atrial diameter, cm
Positive stress echocardiogram
Appropriate indication
Inappropriate indication
Uncertain indication
Abbreviations as in Table 3.by several operators for the evaluation of
multiple different valve lesions.
The development of appropriateness
criteria were a step to improve effective-
ness of noninvasive testing by reducing
the number of unnecessary noninvasive
tests. The criteria were based on score
and classiﬁcation by expert opinion.
Therefore, the only way to validate the
criteria is to test them in patient pop-
ulations and modify them depending on
these results. To our knowledge, our
study is the ﬁrst study to examine the
clinical applicability of appropriateness
criteria for valvular heart disease.edictors of Cardiac Events
Hazard Ratio (95% CI) p Value
0.98 (0.94–1.02) 0.38
0.68 (0.20–2.31) 0.54
1.01 (0.37–6.24) 0.25
2.43 (0.69–8.53) 0.16
2.94 (0.54–16.04) 0.21
0.82 (0.20–3.39) 0.79
0.95 (0.91–0.98) 0.02
1.39 (0.54–3.54) 0.49
2.9 (0.55–7.23) 0.22
1.00 (0.50–2.00) 0.99
15.49 (4.18–57.38) <0.0001
2.1 (0.67–6.25) 0.99
5.4 (0.89–9.23) 0.99
1.52 (0.45–5.20) 0.98Our data show that the clinical value
of the appropriateness criteria is the
ability to differentiate between those
who have a high probability of a positive
stress test result and subsequent cardiac
event/intervention (appropriate studies)
and those with a low probability of a
positive test result and cardiac events
(inappropriate studies). Patients deemed
inappropriate by current appropriateness
criteria are unlikely to have a positive test
result and have an excellent prognosis
without any intervention.
However, there was no signiﬁcant
difference in outcome between the
appropriate and uncertain groups. The
majority of studies classiﬁed by the
appropriateness criteria as uncertainwere
for asymptomatic severe aortic stenosis or
symptomatic patients with mild or mild
to moderate mitral regurgitation/steno-
sis. There is a growing body of evidence
that demonstrates the poor prognosis of
an increase in the mean transaortic gra-
dient of >20 mm Hg in patients with
severe asymptomatic aortic stenosis
(13,14). Recently published European
Society of Cardiology guidelines for
valvular heart disease now recommend
consideration of valve intervention for
asymptomatic severe aortic stenosis in
which the exercise mean transaortic
gradient increases by $20 mm Hg as
a class IIb indication for aortic valve
replacement (17). Studies have demon-
strated that in patients with mild mitral
regurgitation or stenosis, severe dys-
function may develop after exercise
(8–11). Furthermore, the worsening
exercise-induced mitral regurgitation
correlates with symptoms. Quantiﬁca-
tion of mitral regurgitation is based on
the combination of multiple parameters
and maybe classiﬁed being of mild to
moderate severity (18); this entity is not
recognized in the appropriateness cri-
teria. Given the evidence base, guideline
changes and the demonstration that
patients in the uncertain group have the
same number of adverse events as those
in the appropriate group may mean that
these indications should be reclassiﬁed as
appropriate. The inappropriate group
had no valve interventions/cardiac events
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992or positive test results. Therefore, an
updated classiﬁcation would allow dif-
ferentiation between patients with a high
likelihood of signiﬁcant valve disease and
intervention and those in whom the test
is unlikely to uncover signiﬁcant valve
disease.
Previous studies, validating the stress
echocardiography appropriateness cri-
teria for evaluation coronary artery dis-
ease, identiﬁed a number of limitations.
A number of assumptions were needed
to classify the patients, and in 1 study,
19% of studies were graded differently
by 2 graders (4). Our data show good
agreement between the 2 graders. The
grading of studies for valvular heart
disease was a simpler process, mainlyrequiring identiﬁcation of symptoms
and the severity of valve dysfunction.
Study limitations. The sample size of
this study is a limitation. However,
referrals for stress echocardiography
assessment of valvular heart disease are
substantially less frequent than those for
assessment of coronary artery disease.
This study is the ﬁrst to identify the
clinical value of stress echocardiography
for valvular heart disease when incor-
porated into routine clinical practice.
Conclusions
Stress echocardiography for the dynamic
assessment of valvular heart disease
provides prognostic data in a range ofvalve lesions when incorporated into
clinical practice. The appropriateness
criteria for the evaluation of valvular
heart disease provide the ability to dif-
ferentiate between patients at high-
(appropriate group) and low- (inappro-
priate group) risk of subsequent cardiac
events. Reclassiﬁcation of the uncertain
group may improve the differential value
of these criteria and improve their
applicability to current clinical practice.
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